查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493261

美國細胞培養市場規模、佔有率、趨勢分析報告：按產品、按應用、細分市場預測，2024-2030 年

U.S. Cell Culture Market Size, Share & Trends Analysis Report By Product, By Application (Biopharmaceutical Production, Drug Development, Diagnostics, Tissue Culture & Engineering), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國細胞培養市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，到2030年，美國細胞培養市場規模預計將達到109.7億美元，預計2024年至2030年複合年成長率為10.02%。

市場成長預計將受到多種因素的推動，包括生物相似藥和生技藥品的成長、幹細胞研究的進步以及促進細胞疫苗開發的生物製造技術的出現。

COVID-19 大流行增加了對可靠的細胞疫苗製造技術的需求。此外，它還帶來了幾項顯著的科學突破，特別是在疫苗技術的開發和測試方面。 2021 年 8 月，丹納赫宣布 Cytiva 和 Pall 擴大生產規模，以支持新冠病毒藥物和疫苗的開發，並實現細胞培養和基因治療等各種模式的生產擴張，以滿足大流行期間的需求。

近年來，細胞培養技術取得了長足的進步，其應用範圍正在迅速擴大。在生物製藥領域，培養哺乳動物細胞的能力使得大量生產複雜的蛋白質為基礎的藥物成為可能。這提高了生物製藥行業的效率、降低了成本並改善了品管。此外，高產細胞株的推出和培養條件的最佳化也有助於提高生產力和可擴展性。例如，2023年6月，Matika Bio在BIO國際大會上宣布了MatiMax細胞株。此細胞株的特徵是縮短倍增時間，以減少處理時間，提高轉染效率，並以低成本提高滴度。

然而，圍繞生命科學產業所使用的動物和動物衍生產品的倫理影響的認知和爭論不斷增強，在一定程度上阻礙了市場的成長。從動物的飼養條件和手術過程中可能造成的痛苦，到對動物族群的整體影響，人們越來越擔心。然而，無血清和無蛋白培養基產品的引入有望克服這些限制。

美國細胞培養市場報告亮點

  • 到 2023 年，消耗品領域將以 58.0% 的最高收益佔有率引領市場，預計在預測期內將以最快的複合年成長率成長。同時，生物技術和生物製藥公司正在增加研發支出，以開發單株抗體和疫苗等先進生技藥品。
  • 從應用來看，生物製藥製造領域預計將在 2023 年以 31.9% 的最高收益佔有率引領市場，並在預測期內以最快的複合年成長率成長。抗體療法的技術進步，例如雙特異性抗體、抗體片段和抗體衍生物的開發，預計將擴大細胞培養應用的市場模式。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數與趨勢

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 產品經營分析

  • 產品細分儀表板
  • 美國細胞培養市場產品波動分析
  • 2018-2030 年美國細胞培養市場規模與趨勢分析（按產品）
  • 消耗品
    • 2018-2030 年消耗品市場估計與預測
    • 血清
    • 試劑
    • 培養基
  • 裝置
    • 2018-2030 年設備市場估計與預測
    • 文化體系
    • 培養箱
    • 離心機
    • 冷凍儲存裝置
    • 生物安全設備
    • 移液

第5章 應用業務分析

  • 使用細分儀表板
  • 美國細胞培養市場應用變化分析
  • 2018-2030 年美國細胞培養市場規模與趨勢分析（按應用）
  • 生物製藥製造
    • 2018-2030年生物製藥生產市場估計與預測
    • 單株抗體
    • 疫苗生產
    • 其他治療性蛋白質
  • 醫藥開發
  • 診斷
  • 組織培養與工程
  • 細胞/基因治療
  • 毒性試驗
  • 其他用途

第6章 競爭狀況

  • 公司分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • Sartorius AG
    • Danaher
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Corning Inc.
    • Avantor Inc.
    • BD
    • Eppendorf SE
    • Bio-Techne
    • PromoCell GmbH
Product Code: GVR-4-68040-272-0

U.S. Cell Culture Market Growth & Trends:

The U.S. cell culture market size is anticipated to reach USD 10.97 billion by 2030 and is projected to grow at a CAGR of 10.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is expected to be driven by various factors, such as the growth of biosimilars and biologics, advancements in stem cell research, and the emergence of bio-manufacturing technologies that facilitate the development of cell-based vaccines.

The COVID-19 pandemic has resulted in an increased demand for reliable cell-based vaccine production technologies. Furthermore, it has led to a few notable scientific breakthroughs, particularly in the development and testing of vaccine technologies. In August 2021, Danaher announced the manufacturing expansion of Cytiva and Pall which assisted in the drug and vaccine development for COVID and enabled expansion in manufacturing of various modalities such as cell culture and gene therapy to meet the demands during the pandemic.

Cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells. This has led to increased efficiency, reduced costs, and improved quality control in the biopharmaceutical industry. Furthermore, the launch of high-yield cell lines and the optimization of culture conditions have contributed to enhanced productivity and scalability. For instance, in June 2023, Matica Bio launched its MatiMax cell lines at the BIO International Convention. The cell line features faster doubling times to reduce processing timelines, has enhanced transfection efficiencies, and enables increased titer production at a lower cost.

However, the growing awareness and debate surrounding the ethical implications of animals and animal-based products used in the life sciences industry is impeding market growth to a certain extent. Concerns ranging from conditions in which animals are housed and potential pain caused during procedures to the overall impact on the animal population are growing. However, the introduction of serum-free, protein-free media products is expected to overcome these limitations.

U.S. Cell Culture Market Report Highlights:

  • The consumables segment led the market with the largest revenue share of 58.0% in 2023 and are expected to grow at the fastest CAGR during the forecast period. This is attributed to the increased R&D expenditure by biotechnology & biopharmaceutical businesses to develop sophisticated biologics, such as monoclonal antibodies & vaccines
  • Based on application, the biopharmaceutical production segment led the market with the largest revenue share of 31.9% in 2023 and is expected to grow at the fastest CAGR during the forecast period. The technological advancements in antibody therapeutics, such as the development of bispecific antibodies, antibody fragments, and antibody derivatives, are anticipated to expand the market prospects for applications of cell culture

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product Segment
    • 1.1.2. Application Segment
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Primary Research
  • 1.5. Information or Data Analysis:
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables &Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion in the scope of applications for cell culture technology
      • 3.2.1.2. Rising demand for biopharmaceuticals, artificial organs, & vaccine production
      • 3.2.1.3. Growth in demand for serum-free, specialty, and customized media
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent process control in cell culture techniques
      • 3.2.2.2. Scalability issues with culturing methods
      • 3.2.2.3. Ethical concerns regarding the use of animals
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. U.S. Cell Culture Market Product Movement Analysis
  • 4.3. U.S. Cell Culture Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Sera
      • 4.4.2.1. Sera market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Fetal Bovine Serum
      • 4.4.2.2.1. Fetal bovine serum market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Other
      • 4.4.2.3.1. Other market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Reagents
      • 4.4.3.1. Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.2. Albumin
      • 4.4.3.2.1. Albumin market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.3. Other
      • 4.4.3.3.1. Other market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Media
      • 4.4.4.1. Media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2. Serum-free Media
      • 4.4.4.2.1. Serum-free media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2.2. CHO Media
      • 4.4.4.2.2.1. CHO media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2.3. HEK 293 Media
      • 4.4.4.2.3.1. HEK 293 media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2.4. BHK Medium
      • 4.4.4.2.4.1. BHK medium market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2.5. Vero Medium
      • 4.4.4.2.5.1. Vero medium market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2.6. Other Serum-free Media
      • 4.4.4.2.6.1. Other serum-free media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.3. Classical Media
      • 4.4.4.3.1. Classical media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.4. Stem Cell Culture Media
      • 4.4.4.4.1. Stem cell culture media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.5. Chemically Defined Media
      • 4.4.4.5.1. Chemically defined media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.6. Specialty Media
      • 4.4.4.6.1. Specialty media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.7. Other Cell Culture Media
      • 4.4.4.7.1. Other cell culture media market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Culture Systems
      • 4.5.2.1. Culture systems market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Incubators
      • 4.5.3.1. Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Centrifuges
      • 4.5.4.1. Centrifuges market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Cryostorage Equipment
      • 4.5.5.1. Cryostorage equipment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Biosafety Equipment
      • 4.5.6.1. Biosafety equipment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Pipetting
      • 4.5.7.1. Pipetting market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Cell Culture Market Application Movement Analysis
  • 5.3. U.S. Cell Culture Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Biopharmaceutical Production
    • 5.4.1. Biopharmaceutical production market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Monoclonal Antibodies
      • 5.4.2.1. Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Vaccine Production
      • 5.4.3.1. Vaccine production market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Other Therapeutic Proteins
      • 5.4.4.1. Other therapeutic proteins market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Drug Development
    • 5.5.1. Drug development market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Diagnostics
    • 5.6.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Tissue Culture and Engineering
    • 5.7.1. Tissue culture and engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. Cell & Gene Therapy
    • 5.8.1. Cell & gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.9. Toxicity Testing
    • 5.9.1. Toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.10. Other Application
    • 5.10.1. Other applications market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Position Analysis, 2023
  • 6.4. Company Profiles/Listing
    • 6.4.1. Sartorius AG
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. Danaher
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Merck KGaA
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Thermo Fisher Scientific, Inc.
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Corning Inc.
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Avantor Inc.
      • 6.4.6.1. Overview Avantor Inc.
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. BD
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Eppendorf SE
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Bio-Techne
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. PromoCell GmbH
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary sources
  • Table 3 U.S. cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 5 Key companies undergoing expansions
  • Table 6 Key companies undergoing acquisitions
  • Table 7 Key companies undergoing collaborations
  • Table 8 Key companies launching new products
  • Table 9 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. cell culture market: market outlook
  • Fig. 7 U.S. cell culture competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 U.S. cell culture market driver impact
  • Fig. 10 U.S. cell culture market restraint impact
  • Fig. 11 U.S. cell culture market: Product movement analysis
  • Fig. 12 U.S. cell culture market: Product outlook and key takeaways
  • Fig. 13 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Sera market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Fetal bovine serum market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Albumin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Serum-free media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 CHO media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 HEK 293 media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 BHK medium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Vero medium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Other serum-free media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Classical media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Stem cell culture media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Chemically defined media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Specialty media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Other cell culture media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Culture systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Incubators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Centrifuges market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Cryostorage equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Biosafety equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Pipetting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.S cell culture market: Application movement analysis
  • Fig. 40 U.S cell culture market: Application outlook and key takeaways
  • Fig. 41 Biopharmaceutical production market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Vaccines production market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Other therapeutic proteins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Drug development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Tissue culture & engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Cell & gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Toxicity testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Market positioning of key market players - U.S cell culture market